iBio files Form 3 for Chief Medical Officer Molly Carr
IBIO•iBio files initial beneficial ownership statement
iBio filed an initial beneficial ownership statement for Chief Medical Officer Molly Carr, dated July 31, 2026.
Related News
Broadridge quarterly profit climbs on investor communications strength
BR•
Sunoco Q2 FY26 net income more than doubles to $283 million; revenue rises to $14.26 billion
SUN•
Superior Group Q2 profit beats on strong branded products segment performance
SGC•
Turning Point Brands tops Q2 sales estimates on modern oral product growth
TPB•
Cummins Q2 Sales USD 9,500 Million Vs. IBES Estimate USD 9,330 Million
CMI•